rotenone has been researched along with Developmental Psychomotor Disorders in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hu, S; Mao, Y; Wang, J; Wang, R; Xie, J; Zhao, X | 1 |
Andrabi, SS; Parveen, S; Parvez, S; Rasheed, MZ; Salman, M; Shaquiquzzaman, M; Tabassum, H | 1 |
Flatters, SJ; Griffiths, LA | 1 |
Abo-Elmatty, DM; Shaalan, AA; Zaitone, SA | 1 |
1 trial(s) available for rotenone and Developmental Psychomotor Disorders
Article | Year |
---|---|
Pharmacological Modulation of the Mitochondrial Electron Transport Chain in Paclitaxel-Induced Painful Peripheral Neuropathy.
Topics: Animals; Antimycin A; Antineoplastic Agents, Phytogenic; Disease Models, Animal; Electron Transport; Electron Transport Chain Complex Proteins; Enzyme Inhibitors; Hyperalgesia; Male; Motor Activity; Paclitaxel; Pain; Pain Measurement; Peripheral Nervous System Diseases; Psychomotor Disorders; Rats; Rats, Sprague-Dawley; Rotenone; Single-Blind Method; Time Factors | 2015 |
3 other study(ies) available for rotenone and Developmental Psychomotor Disorders
Article | Year |
---|---|
Neuroprotective effect of resveratrol on rotenone-treated C57BL/6 mice.
Topics: Animals; Disease Models, Animal; Dopaminergic Neurons; Insecticides; Iron; Male; Mice; Mice, Inbred C57BL; Neurodegenerative Diseases; Neuroprotective Agents; Psychomotor Disorders; Random Allocation; Resveratrol; Rotarod Performance Test; Rotenone; Stilbenes; Substantia Nigra; Tyrosine 3-Monooxygenase | 2017 |
Melatonin Improves Behavioral and Biochemical Outcomes in a Rotenone-Induced Rat Model of Parkinson's Disease.
Topics: Animals; Disease Models, Animal; Male; Melatonin; Muscle Strength; Neurotoxins; Neurotransmitter Agents; Parkinson Disease; Postural Balance; Psychomotor Disorders; Rats; Rats, Wistar; Rotenone; Tyrosine 3-Monooxygenase | 2018 |
Acetyl-L-carnitine and α-lipoic acid affect rotenone-induced damage in nigral dopaminergic neurons of rat brain, implication for Parkinson's disease therapy.
Topics: Acetylcarnitine; Adenosine Triphosphate; Animals; Antioxidants; Dietary Supplements; Dopamine; Dopaminergic Neurons; Hypokinesia; Lipid Peroxides; Male; Mitochondria; Neuroprotective Agents; Parkinson Disease; Protein Carbonylation; Psychomotor Disorders; Random Allocation; Rats; Rotenone; Substantia Nigra; Survival Analysis; Thioctic Acid; Vitamin B Complex | 2012 |